CPT-157633

• CAT Number: I045629
• CAS Number: 888213-72-7
• Molecular Formula: C12H16BrF2N2O6PS
• Molecular Weight: 465.20
• Purity: ≥95%
• Synonyms: [[2-bromo-4-[(2S)-2-(methanesulfonamido)-3-(methylamino)-3-oxopropyl]phenyl]-difluoromethyl]phosphonic acid
• InChI: InChI=1S/C12H16BrF2N2O6PS/c1-16-11(18)10(17-25(2,22)23)6-7-3-4-8(9(13)5-7)12(14,15)24(19,20)21/h3-5,10,17H,6H2,1-2H3,(H,16,18)(H2,19,20,21)/t10-/m0/s1
• InChIKey: GNQQLTLSVIWPPQ-JTQLQIEISA-N
• SMILES: CNC(=O)C(CC1=CC(=C(C=C1)C(F)(F)P(=O)(O)O)Br)NS(=O)(=O)C

CPT-157633 (Cat No.: I045629) is a synthetic research compound explored for its potential pharmacological activity in disease-relevant signaling pathways. As an experimental small molecule, it serves as a tool for probing biochemical mechanisms, evaluating target interactions, and investigating structure–activity relationships in preclinical studies. While its therapeutic applications remain undefined, CPT-157633 is valuable in advancing drug discovery efforts and deepening understanding of molecular regulation. Its role highlights ongoing scientific interest in identifying innovative compounds that may contribute to future therapeutic strategies across diverse biomedical fields.

Reference

[1]. Lindtner C, et, al. Binge drinking induces whole-body insulin resistance by impairing hypothalamic insulin action. Sci Transl Med. 2013 Jan 30;5(170):170ra14.
[Content Brief]